Viewing Study NCT03419234


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 1:04 AM
Study NCT ID: NCT03419234
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2018-01-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module